OMER, Israel, May 24, 2012 /PRNewswire/ -- The SRS system by Medigus, offers endoluminal treatment for one of the most common chronic conditions Medigus Ltd.

For many people with gastroesophageal reflux disease or GERD, acid reflux drugs are the answer to their woes, curbing the chronic heartburn and regurgitation of food or sour liquid characteristic of the disorder.

With global obesity levels rising, an increasing number of people find themselves suffering from acid reflux, which in turn could lead to a higher rate of those contracting esophageal cancer.

Takeda Pharmaceuticals North America, Inc., (Takeda) announced the DEXILANT (dexlansoprazole) product labeling now includes information from a study in healthy subjects demonstrating that DEXILANT

DEERFIELD, Ill., Nov.